Use of a Microendoscope for Transtympanic Drug Delivery to the Round Window Membrane in Chinchillas

Introduction Systemic drug application for the treatment of inner ear diseases is restricted because of the blood-labyrinthine barrier and the limited blood supply to the inner ear. Local drug delivery to the inner ear can be an alternative method to overcome the problems with systemic application. The purpose of the present study was to describe the anatomic orientation of the round window membrane (RWM) and to examine the use of a microendoscope for transtympanic drug delivery to the RWM in the chinchilla animal model. Materials and Methods Fourteen female chinchillas were used for anatomic dissections (n = 4, 8 ears) and comparison of otomicroscopy (n = 5, 10 ears) with otoendoscopy (n = 5, 10 ears) for visualization and transtympanic application of methylene blue to the RWM of the animals. Results The external auditory meatus in chinchillas is S-shaped, and the RWM is not accessible through the tympanic membrane in otomicroscopy. The use of a special microendoscope makes it relatively easy to have an accurate transtympanic access to the RWM. The working channel of the microendoscope permitted successful delivery of methylene blue to the RWM in all tested chinchillas. Conclusion The present study is the first published study that shows the feasibility of a microendoscope for transtympanic drug delivery to the RWM in animal models. Minor technical modifications are recommended, which will make the microendoscope an easy tool for future studies on local drug delivery to the RWM in the chinchilla animal model.

[1]  H. Schuknecht Ablation therapy for the relief of meniere's disease , 1956, The Laryngoscope.

[2]  J. D. Miller Audibility curve of the chinchilla. , 1963, The Journal of the Acoustical Society of America.

[3]  J. Niparko,et al.  Anatomy of the round Window Niche , 1986, The Annals of otology, rhinology, and laryngology.

[4]  S. P. Dear,et al.  Middle ear structure in the chinchilla: a quantitative study. , 1988, American journal of otolaryngology.

[5]  A. Hodges,et al.  Cochlear Endoscopy with Preservation of Hearing in Guinea Pigs , 1994, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[6]  H. Silverstein,et al.  Direct Round Window Membrane Application of Gentamicin in the Treatment of Meniere's Disease , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[7]  M V Goycoolea,et al.  Clinical Aspects of Round Window Membrane Permeability Under Normal and Pathological Conditions , 2001, Acta oto-laryngologica.

[8]  H. Silverstein,et al.  Chemical perfusion of the inner ear. , 2002, Otolaryngologic clinics of North America.

[9]  P. Plinkert,et al.  Transtympanic endoscopy for drug delivery to the inner ear using a new microendoscope. , 2002, Advances in oto-rhino-laryngology.

[10]  H. Silverstein,et al.  Inner ear perfusion: indications and applications , 2003, Current Opinion in Otolaryngology & Head and Neck Surgery.

[11]  P. Barr,et al.  Protease inhibitors α1‐antitrypsin and ilomastat are not ototoxic in the chinchilla , 2003, The Laryngoscope.

[12]  Adam K Pack,et al.  Direct Round Window Application of Gentamicin with Varying Delivery Vehicles: A Comparison of Ototoxicity , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[13]  T. Okuno,et al.  Permeability of the round window membrane , 2004, Archives of oto-rhino-laryngology.

[14]  P. Weisskopf,et al.  Sustained-release devices in inner ear medical therapy. , 2004, Otolaryngologic clinics of North America.

[15]  H. Silverstein,et al.  Transtympanic perfusion: indications and limitations , 2004, Current opinion in otolaryngology & head and neck surgery.

[16]  A. Gamst,et al.  Intratympanic Gentamicin Therapy for Ménière’s Disease: A Meta-analysis , 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[17]  J. Ito,et al.  Drug Delivery to the Cochlea Using PLGA Nanoparticles , 2005, The Laryngoscope.

[18]  T. Brozoski,et al.  Cochlear structure and function after round window application of ototoxins , 2005, Hearing Research.

[19]  R. Stokroos,et al.  Intratympanic steroid therapy for inner ear diseases, a review of the literature , 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[20]  J. Schellens,et al.  Future opportunities in preventing cisplatin induced ototoxicity. , 2006, Cancer treatment reviews.

[21]  C. Klingmann,et al.  Transsynaptic delivery of nanoparticles to the central auditory nervous system , 2007, Acta oto-laryngologica.

[22]  B. Serbetcioglu,et al.  The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[23]  Efficiency of a transtympanic approach to the round window membrane using a microendoscope , 2009, European Archives of Oto-Rhino-Laryngology.

[24]  Hao Jiang,et al.  A Novel Controlled Local Drug Delivery System for Inner Ear Disease , 2008, The Laryngoscope.

[25]  S. Eksborg,et al.  Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity , 2009, Journal of the National Cancer Institute.

[26]  Robert C. Borden,et al.  Hyaluronic Acid Hydrogel Sustains the Delivery of Dexamethasone across the Round Window Membrane , 2010, Audiology and Neurotology.

[27]  Oliver F. Adunka,et al.  Flexible cochlear microendoscopy in the gerbil , 2010, The Laryngoscope.